Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
December 27, 2022
Patent Application Number
17149302
Date Filed
January 14, 2021
Patent Citations Received
0
Patent Primary Examiner
One embodiment of the disclosure is a compound represented by Formula I or a pharmaceutically acceptable salt thereof. The variables in Formula I are defined herein. Compounds of Formula I are selective MAP4K1 inhibitors, which can be used to treat a diseases or disorders in a subject that benefits from control of MAP4K1 activity.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
